Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sigyn Therapeutics's revenue for the twelve months ending Sep 30, 2020 was $9.93K. For fiscal 2019 it was $143.32K, up 405.6% from the year before. The highest annual figure on record is $143.32K in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $143.32K | +405.6% |
| FY2018 | Dec 31, 2018 | $28.35K | -26.2% |
| FY2017 | Dec 31, 2017 | $38.43K | +31.6% |
| FY2015 | Dec 31, 2015 | $29.21K | -32.3% |
| FY2014 | Dec 31, 2014 | $43.15K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $3.83K | -88.1% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $756 | -98.2% |
| Q4 FY2019 | Dec 31, 2019 | $5.34K | -94.1% |
| Q3 FY2019 | Sep 30, 2019 | $32.10K | +456.3% |
| Q2 FY2019 | Jun 30, 2019 | $64.33K | +177.9% |
| Q1 FY2019 | Mar 31, 2019 | $41.55K | -83.8% |
| Q3 FY2018 | Sep 30, 2018 | $90.45K | -79.1% |
| Q2 FY2018 | Jun 30, 2018 | $5.77K | -97.9% |
| Q1 FY2018 | Mar 31, 2018 | $23.15K | – |
| Q3 FY2017 | Sep 30, 2017 | $255.98K | – |
| Q2 FY2017 | Jun 30, 2017 | $432.53K | – |
| Q1 FY2017 | Mar 31, 2017 | $268.93K | – |
| Q4 FY2015 | Dec 31, 2015 | $0 | – |
See a number that looks wrong?